
Annual healthcare costs jump by almost $25,000 with targeted therapy for atopic dermatitis that avoided costs from reduced hospitalizations and ER visits only partly offset, according to recently reported research findings.
As an educator at Harvard Medical School, scientist, researcher, former senior executive of a hospital-based health system, national spokesperson, and executive vice president and chief medical officer of Anthem Inc., Samuel Nussbaum, MD, certainly has the credentials to lead the industry in the clinical quality and healthcare management arena.






